Literature DB >> 25242332

PROX1 promotes metabolic adaptation and fuels outgrowth of Wnt(high) metastatic colon cancer cells.

Simone Ragusa1, Jianpin Cheng1, Konstantin I Ivanov1, Nadine Zangger2, Fatih Ceteci3, Jeremiah Bernier-Latmani1, Stavros Milatos1, Jean-Marc Joseph4, Stephane Tercier4, Hanifa Bouzourene5, Fredrik T Bosman6, Igor Letovanec6, Giancarlo Marra7, Michel Gonzalez8, Patrizia Cammareri3, Owen J Sansom3, Mauro Delorenzi9, Tatiana V Petrova10.   

Abstract

The Wnt pathway is abnormally activated in the majority of colorectal cancers, and significant knowledge has been gained in understanding its role in tumor initiation. However, the mechanisms of metastatic outgrowth in colorectal cancer remain a major challenge. We report that autophagy-dependent metabolic adaptation and survival of metastatic colorectal cancer cells is regulated by the target of oncogenic Wnt signaling, homeobox transcription factor PROX1, expressed by a subpopulation of colon cancer progenitor/stem cells. We identify direct PROX1 target genes and show that repression of a pro-apoptotic member of the BCL2 family, BCL2L15, is important for survival of PROX1(+) cells under metabolic stress. PROX1 inactivation after the establishment of metastases prevented further growth of lesions. Furthermore, autophagy inhibition efficiently targeted metastatic PROX1(+) cells, suggesting a potential therapeutic approach. These data identify PROX1 as a key regulator of the transcriptional network contributing to metastases outgrowth in colorectal cancer.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25242332     DOI: 10.1016/j.celrep.2014.08.041

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  33 in total

1.  Positive regulation of β-catenin-PROX1 signaling axis by DBC1 in colon cancer progression.

Authors:  E J Yu; S-H Kim; H J Kim; K Heo; C-Y Ou; M R Stallcup; J H Kim
Journal:  Oncogene       Date:  2015-10-19       Impact factor: 9.867

2.  Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis.

Authors:  Pengcheng Bu; Kai-Yuan Chen; Kun Xiang; Christelle Johnson; Scott B Crown; Nikolai Rakhilin; Yiwei Ai; Lihua Wang; Rui Xi; Inna Astapova; Yan Han; Jiahe Li; Bradley B Barth; Min Lu; Ziyang Gao; Robert Mines; Liwen Zhang; Mark Herman; David Hsu; Guo-Fang Zhang; Xiling Shen
Journal:  Cell Metab       Date:  2018-04-26       Impact factor: 27.287

3.  IMP1 3' UTR shortening enhances metastatic burden in colorectal cancer.

Authors:  Sarah F Andres; Kathy N Williams; Jacqueline B Plesset; Jeffrey J Headd; Rei Mizuno; Priya Chatterji; Ashley A Lento; Andres J Klein-Szanto; Rosemarie Mick; Kathryn E Hamilton; Anil K Rustgi
Journal:  Carcinogenesis       Date:  2019-06-10       Impact factor: 4.944

4.  Prox1 inhibits neurite outgrowth during central nervous system development.

Authors:  Valeria Kaltezioti; Iosifina P Foskolou; Matthieu D Lavigne; Elpinickie Ninou; Matina Tsampoula; Maria Fousteri; Marigoula Margarity; Panagiotis K Politis
Journal:  Cell Mol Life Sci       Date:  2020-11-28       Impact factor: 9.261

5.  Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis.

Authors:  Nadine Rohwer; Sandra Jumpertz; Merve Erdem; Antje Egners; Klaudia T Warzecha; Athanassios Fragoulis; Anja A Kühl; Rafael Kramann; Sabine Neuss; Ines Rudolph; Tobias Endermann; Christin Zasada; Ivayla Apostolova; Marco Gerling; Stefan Kempa; Russell Hughes; Claire E Lewis; Winfried Brenner; Maciej B Malinowski; Martin Stockmann; Lutz Schomburg; William Faller; Owen J Sansom; Frank Tacke; Markus Morkel; Thorsten Cramer
Journal:  Oncogene       Date:  2019-05-01       Impact factor: 9.867

6.  c-MAF coordinates enterocyte zonation and nutrient uptake transcriptional programs.

Authors:  Alejandra González-Loyola; Jeremiah Bernier-Latmani; Irena Roci; Tania Wyss; Jakob Langer; Stephan Durot; Olivia Munoz; Borja Prat-Luri; Mauro Delorenzi; Matthias P Lutolf; Nicola Zamboni; Grégory Verdeil; Tatiana V Petrova
Journal:  J Exp Med       Date:  2022-09-19       Impact factor: 17.579

7.  Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice.

Authors:  Simone Ragusa; Borja Prat-Luri; Alejandra González-Loyola; Sina Nassiri; Mario Leonardo Squadrito; Alan Guichard; Sabrina Cavin; Nikolce Gjorevski; David Barras; Giancarlo Marra; Matthias P Lutolf; Jean Perentes; Emily Corse; Roberta Bianchi; Laureline Wetterwald; Jaeryung Kim; Guillermo Oliver; Mauro Delorenzi; Michele De Palma; Tatiana V Petrova
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

8.  Impact of prospero homeobox-1 on tumor cell behavior and prognosis in colorectal cancer.

Authors:  Young-Lan Park; Eun Myung; Sun-Young Park; Nuri Kim; Chan-Young Oak; Dae-Seong Myung; Sung-Bum Cho; Wan-Sik Lee; Sun-Seog Kweon; Hyun-Soo Kim; Young-Eun Joo
Journal:  Am J Cancer Res       Date:  2015-10-15       Impact factor: 6.166

9.  Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells.

Authors:  Dongwon Choi; Swapnika Ramu; Eunkyung Park; Eunson Jung; Sara Yang; Wonhyeuk Jung; Inho Choi; Sunju Lee; Kyu Eui Kim; Young Jin Seong; Mingu Hong; George Daghlian; Daniel Kim; Eugene Shin; Jung In Seo; Vicken Khatchadourian; Mengchen Zou; Wei Li; Roger De Filippo; Paul Kokorowski; Andy Chang; Steve Kim; Ana Bertoni; Tania Weber Furlanetto; Sung Shin; Meng Li; Yibu Chen; Alex Wong; Chester Koh; Jan Geliebter; Young-Kwon Hong
Journal:  Cancer Res       Date:  2015-11-25       Impact factor: 12.701

10.  The Molecular Basis of Metastatic Colorectal Cancer.

Authors:  Sarah F Andres; Kathy N Williams; Anil K Rustgi
Journal:  Curr Colorectal Cancer Rep       Date:  2018-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.